| Stage | PRGS | % of rev | ABM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $246M | 100.00% | $2.3B | 100.00% | ABM ×9.42 |
| Gross profit | $204M | 82.74% | $286M | 12.35% | PRGS +70.4pp |
| Operating income | $47M | 18.92% | $92M | 3.95% | PRGS +15.0pp |
| Pre-tax income | $30M | 12.01% | $63M | 2.73% | PRGS +9.3pp |
| Net income | $23M | 9.26% | $50M | 2.14% | PRGS +7.1pp |
| Stage | PRGS | ABM | Gap · A − B |
|---|---|---|---|
| Revenue | $246M100.00% | $2.3B100.00% | ABM ×9.42 |
| Gross profit | 82.74%$204M | 12.35%$286M | PRGS +70.4pp |
| Operating income | 18.92%$47M | 3.95%$92M | PRGS +15.0pp |
| Pre-tax income | 12.01%$30M | 2.73%$63M | PRGS +9.3pp |
| Net income |
| 9.26%$23M |
| 2.14%$50M |
| PRGS +7.1pp |
No shared counterparties.